Postmenopausal Female Patients: Clinical Trials

3 trials for Postmenopausal Female Patients, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed. 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 2
Phase 21Completed 1

Follow Postmenopausal Female Patients: new trials by email Literature Review of Postmenopausal Female Patients trials Research Report on Postmenopausal Female Patients

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Female-Specific Modifiers for Healthy Early Action in Cardiovascular Risk Trajectories
Personal training, App-based physical intervention - Perimenopausal Women, Postmenopausal Female Patients
Not applicableNot yet recruitingLudwig Boltzmann Institute for Cardiovascular Research6052027-06-012026-07-21
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females on Hormone Therapy
Moderate Intensity Exercise (MIE), High intensity exercise (HIE), Control (No exercise) - Postmenopausal Female Patients, Vasomotor Symptoms
Not applicableNot yet recruitingUniversity of Virginia242026-10-152026-10-16
DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).
Ribociclib, Eribulin - HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer, HER2-negative Circulating Tumor Cells
Phase 2CompletedProf. Wolfgang Janni1162014-01-012024-06-04

Narrower conditions

Breast Neoplasms (1)  ·  Neoplastic Cells, Circulating (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

High-Intensity Interval Training (1)  ·  eribulin (1)  ·  ribociclib (1)

Sponsors

Ludwig Boltzmann Institute for Cardiovascular Research (1)  ·  Prof. Wolfgang Janni (1)  ·  University of Virginia (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Jason Allen (1)  ·  Tanja Fehm, MD, PhD (1)  ·  Wolfgang Janni, MD, PhD (1)

Results publications

PMID 42747616